Home › Science › GLP-1 drugs could have a surprisingly large environmental payoff
Science

GLP-1 drugs could have a surprisingly large environmental payoff

GLP-1 drugs could have a surprisingly large environmental payoff
Key Points

GLP-1 weight-loss medicines such as Ozempic and Wegovy could affect much more than the waistlines of the people who take them. If widely used, our new research suggests these appetite-suppressing medicines could transform the global food system and free up vast areas of agricultural land. The global food system is ultimately driven by demand.

GLP-1 weight-loss medicines such as Ozempic and Wegovy could affect much more than the waistlines of the people who take them. If widely used, our new research suggests these appetite-suppressing medicines could transform the global food system and free up vast areas of agricultural land.

The global food system is ultimately driven by demand. If people eat less, producers respond, affecting production, prices, trade, and how much land is needed. We used a powerful computer simulation to explore scenarios ranging from GLP-1 use concentrated in high-income countries to widespread global access.

With widespread use of these medicines among adults living with obesity, we estimate that reduced calorie intake could prevent up to 6.6 million deaths each year by 2050, while freeing up as much as 32 million hectares of agricultural land—an area slightly larger than Italy—for other uses.

Read full article

Comments

Ozempic and Wegovy (ORG) Italy (LOCATION)
Originally published by Ars Technica Read original →